{"nct_id":"NCT03704077","title":"An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma","status":"WITHDRAWN","status_verified_date":"2020-05","start_date":"2019-10-31","start_date_type":"ESTIMATED","primary_completion_date":"2022-02-27","primary_completion_date_type":"ESTIMATED","completion_date":"2024-09-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}